The global pharmaceutical industry will have spent more than $10 billion on cold chain logistics in 2015, getting products and clinical trial supplies into pharmacies and hospitals all over the world. Millions of miles have been travelled under the GxP regulations with every consignment controlled. Then the dreaded moment comes as we enter the “last mile”. Despite all the efforts to ensure correct storage conditions en route, the package will be handed to site staff or to the patient. Is this the point all our collective efforts are in vain? Read more...
Getting a clinical trial drug into China is a complex business. Any discrepancies in paperwork or the physical shipment can lead to delays at customs or China Inspection & Quarantine. World Courier shares its experience for successful shipping.
Down at the base of Africa is a country with amazing heritage, unique geography, and challenging patient populations. See why clinical trials happen in South Africa here
In globalising the pharmaceutical industry oversight and control has increasingly become a challenge in managing product quality, consumer safety and organisational risk.
Once deficiencies in the supply chain are identified, how can the pharmaceutical industry ensure it manages product quality, consumer safety and organizational risk?
Southeast Asia is a growing pharmaceutical market, with a population of 620 million. What opportunities are there for multinational companies to access this rich area?